Odonate Therapeutics, Inc. Financial Statements 2011-2024 | ODT

Annual Financial Statements Odonate Therapeutics, Inc.

	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	759 M	812 M	398 M	301 M	-	-	-	-	-	-
Shares	32.8 M	27.6 M	24.5 M	14.2 M	-	-	-	-	-	-
Net Income	-126 M	-112 M	-89 M	-32.7 M	-3.08 M	-158 K	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-
EBITDA	-127 M	-115 M	-90.4 M	-32.7 M	-3.08 M	-158 K	-	-	-	-
Operating Expenses	127 M	115 M	90.8 M	-	-	-	-	-	-	-
General and Administrative Expenses	10.4 M	10.9 M	10.8 M	4.84 M	463 K	158 K	-	-	-	-

All numbers in USD currency